4//SEC Filing
ABERCROMBIE GEORGE B 4
Accession 0001127602-22-012272
CIK 0000882796other
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 4:23 PM ET
Size
8.1 KB
Accession
0001127602-22-012272
Insider Transaction Report
Form 4
ABERCROMBIE GEORGE B
Director
Transactions
- Sale
Common Stock
2022-04-18$11.04/sh−5,000$55,200→ 0 total - Exercise/Conversion
Common Stock
2022-04-18$3.32/sh+5,000$16,600→ 5,000 total - Exercise/Conversion
Automatic Stock Option Grant
2022-04-18−5,000→ 0 totalExercise: $3.32Exp: 2022-05-23→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021.
- [F2]The option vested 1/12 per month for a period of 12 months, beginning on June 23, 2012.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001485939
Filing Metadata
- Form type
- 4
- Filed
- Apr 19, 8:00 PM ET
- Accepted
- Apr 20, 4:23 PM ET
- Size
- 8.1 KB